Jounce Therapeutics, Inc. (JNCE) Social Stream
Jounce Therapeutics Inc (JNCE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Jounce Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
JNCE's average price target has moved up $0.3 over the prior 131 days.
Over the past 131 days, JNCE's average upside potential has been 118.75%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
JNCE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
JNCE's average broker recommendation rating improved by 0.34 over the prior 120 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Jounce Therapeutics Inc's variance in analysts' estimates is lower than 59.26% of them.
- In the context of all US stocks, Jounce Therapeutics Inc's average analyst price target is higher than 50.14% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Jounce Therapeutics Inc's number of analysts covering the stock is greater than 250.68% of them.
- JNCE has a higher upside potential (average analyst target price relative to current price) than 120.75% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Jounce Therapeutics Inc are ITOS, IPSC, and IPHA.
Make investment decisions regarding JNCE using the data that counts. Try POWR Ratings for free.